GELS GELS
Company Profile ↓Company Overview
GELS (GELS) is a publicly traded company listed on with a market capitalization of $5.62M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.27.
Recent Developments
- 5-Year Trend Long-term compounding — revenue CAGR 3.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.93% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -66.52% |
| 6 Months: | -33.48% |
| 3 Months: | +0.73% |
| 1 Month: | -2.91% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)46.01 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 66.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 147.54K | 79.84K | 0 | 165.65K |
| Cost of Revenue | 94.87K | 48.92K | 0 | - |
| Gross Profit | 52.66K | 30.92K | 0 | - |
| Operating Expenses | 3.25M | 3.41M | 2.61M | 5.12M |
| Operating Income | -3.19M | -3.38M | -2.61M | -4.95M |
| EBITDA | -1.98M | -1.88M | -1.75M | -3.53M |
| Interest Expense | 174.50K | 403.52K | 585.12K | 1.89M |
| Pretax Income | -3.37M | -3.51M | -3.55M | -6.65M |
| Tax Provision | 0 | 0 | 0 | 0 |
| Net Income | -3.37M | -3.51M | -3.55M | -6.65M |
| Diluted EPS | -0.36 | -0.37 | -0.38 | -0.72 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 23.41M | 22.49M | 20.76M | 21.48M |
| Current Assets | 720.07K | 990.97K | 303.23K | 1.51M |
| Cash & Equivalents | 162.49K | 399.22K | 24.52K | 344.65K |
| Inventory | 95.20K | 95.20K | 0 | - |
| Receivables | 7.98K | 82.23K | 8.25K | 45.93K |
| Total Liabilities | 2.55M | 3.84M | 5.65M | 5.67M |
| Current Liabilities | 1.08M | 1.36M | 3.87M | 5.63M |
| Long Term Debt | 1.46M | 2.47M | 1.76M | 13.55K |
| Total Debt | 1.51M | 2.49M | 3.84M | 4.22M |
| Total Equity | 20.86M | 18.66M | 15.11M | 15.80M |
| Shares Outstanding | 9.44M | 9.44M | 9.44M | 10.03M |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - |
| Investing Cash Flow | 0 | -75.93K | -148.17K | -736.84K |
| Financing Cash Flow | 1.49M | 2.03M | 843.94K | 6.45M |
| Capital Expenditure | - | -75.93K | -148.17K | -642.23K |
| Free Cash Flow | -1.51M | -1.85M | -1.22M | -6.16M |
| Net Change in Cash | -20.20K | 184.18K | -374.70K | 195.06K |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 35.7% | 38.7% | - | - |
| Operating Margin % | -2,165.1% | -4,232.9% | - | -2,989.0% |
| Net Margin % | -2,283.4% | -4,391.4% | - | -4,011.9% |
| ROE % | -16.2% | -18.8% | -23.5% | -42.0% |
| ROCE % | -14.3% | -16.0% | -15.4% | -31.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GELS
Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcF9ONmRSSEdLUHhmOUdPdi1GTTBlNjI0SmJlaV9JZGdzRUlTbnBiMkN5NFZtVlVkLUE0aUsxWWtLUy1yc1VObmlfdDFEbFpBc0xaRks3cjhqYUVnek1aY3NBSnFGX0s5cVY2WWg5YllBOGVXYUtvNG0wSmlLdVEyRGxhR0p4b3pqV0N4M2…
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFA2Qkt2ODcwNHluNU81S0tPaTJCamQzSGdmTTNSU3dwdWNfMzJ5eVM5azhQZ1RmRnRIbHhzS2xILTRtb21tOEQ3U2xzV1lBS3ZhM1BtSVUweUdRS3NJdzFxTC04emg5UDZzNW02cmVBMWt1b2hrd3c?oc=5" target="_blank">GELS Sto…
GELS Stock Rockets On Momentum As Traders Pile In - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE5YaDd6OUY2RHpqajBxWG0wVk4ycjU0UUhTTjdtMlYteF9OWmhVMGFZV3U4SkF2Z0VaTVNVSmppY2UtTTJrSms4Ung2QkpQRDQwaVNBS0xHWFJIMW1xOE14blRWUkpTS0ZQWndfWXZCQmVwcUtx?oc=5" target="_blank">GELS Stock …
Gelteq Limited Revenue Breakdown – NASDAQ:GELS - TradingView
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE4tRTFzZXV4Ym5VVUtpcXVRUkVhOFR5b0ZRTjRVYkw5bVZzRS1UX3R4N0NBRFA0TnlRcEh4TmFpb1AwLVlkM0JzS0d2VWtLeFRVcDFCYjYwN21NNko2cWZhTVh4V1plWVdSVWF2R3pmSVdPQmFoejRN?oc=5" target="_blank">Gelteq …
What's Going On With Gelteq Stock Friday? - Benzinga
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNZ241SENvT2J5Rkg2V0lZNk9oREtvbnktTkVENnNwWGJMQUxTeEJ4R1hBemM0VW5HRkg4am1hR2JUckJIWFJCYmwxMHpweXJ3VVN4aHMzTDJLMmJTT1BBRWl1QzNMNkFZZ1NwRk9mV0pTWG84dnUtUUxEcGE1Mkh5Q1hxZGtKS1J4dWttWG…
Traders are paying attention to the gapping stocks in Friday's session. - ChartMill
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNS0FuaFBCNDk2bVh0YWRfYUVZckhkTlF5WHQ1SFBHaVpVRmJ4eVlWQ3pVTE00b3hJLU9XaEhXVlJRcU92SzR1V2RzOF9mMU5nZ0JvQ2hGekpVMEo0TjVOdVhvRWh6YlFKQXMwSUstSm5FVXV4R1hGeE9BTHBkc016dlNWTi1SUWpJOG9PX0…
GELS — Frequently Asked Questions
What is the current share price of GELS?
As of 2026-08-05 17:25 PDT, GELS trades at $0.56 on NASDAQ/NYSE. Its 52-week range is $0.39 to $1.68.
What is the market capitalisation of GELS?
GELS has a market capitalisation of $5.62M on NASDAQ/NYSE.
What is the P/E ratio of GELS?
GELS trades at a trailing price-to-earnings (P/E) ratio of -0.78. Its price-to-book (P/B) ratio is 0.36.
What is the return on equity (ROE) of GELS?
GELS has a return on equity (ROE) of -42.05%. Its return on capital employed (ROCE) is -31.25%.
Is GELS a good stock to buy?
This page provides a data-driven analysis of GELS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.